India Pharma Forecast Record Growth For 2023 Ahead of CPHI & PMEC India
Amsterdam, 16th November 2022: India is set for record growth in
2023 after pharma manufacturers report surging international partnering
at CPHI Frankfurt. Contract Manufacturing organisations (CMO) appear to
be the biggest beneficiaries of new contracts, closely followed by API
manufacturers in the country. In fact, for the first time Indian API
manufacturing has surpassed the quality scores of even Europe’s leading
API hub – Italy – in the CPHI Annual Survey.
More info >> |